Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
62.1M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
17.2M
-
Shares change
-
+2.21M
-
Total reported value, excl. options
-
$208M
-
Value change
-
+$26.4M
-
Number of buys
-
43
-
Number of sells
-
-27
-
Price
-
$12.11
Significant Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q2 2019
74 filings reported holding PTGX - Protagonist Therapeutics, Inc - Common Stock as of Q2 2019.
Protagonist Therapeutics, Inc - Common Stock (PTGX) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.2M shares
of 62.1M outstanding shares and own 27.67% of the company stock.
Largest 10 shareholders include FMR LLC (3.51M shares), FARALLON CAPITAL MANAGEMENT LLC (1.5M shares), VHCP Management III, LLC (1.07M shares), BVF INC/IL (1.06M shares), BlackRock Inc. (1.02M shares), BAKER BROS. ADVISORS LP (995K shares), MILLENNIUM MANAGEMENT LLC (811K shares), VANGUARD GROUP INC (800K shares), DIMENSIONAL FUND ADVISORS LP (744K shares), and ACUTA CAPITAL PARTNERS, LLC (672K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.